Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Feasibility of the ELIOS System in POAG Patients

NCT: NCT05999006 · COMPLETED

NCT IDNCT05999006
StatusCOMPLETED
Start Date2023-10-18
Completion2026-04-28
SponsorElios Vision, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

Frequently Asked Questions

What is Safety and Feasibility of the ELIOS System in POAG Patients?

Safety and Feasibility of the ELIOS System in POAG Patients is a clinical trial registered under NCT05999006. Current status: COMPLETED.

What is the status of NCT05999006?

The current status of NCT05999006 (Safety and Feasibility of the ELIOS System in POAG Patients) is: COMPLETED.

When did Safety and Feasibility of the ELIOS System in POAG Patients start?

Safety and Feasibility of the ELIOS System in POAG Patients started on 2023-10-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.